Pr Mahasti Saghatchian

Spécialité

Oncologue médical, expert sein

Titre

Chef de service

Hôpital

Hôpital Américain (Paris)

Derniers articles

• HERmione: Understanding the Needs of Patients Living with Metastatic HER2-Positive Breast Cancer Through a Cross-Sectional Survey in Parallel with Patients and Oncologists. (17 avr. 2025)
• Leveraging G-CSF prescribing in the outpatient setting: considerations beyond clinical factors-a questionnaire study. (14 mai 2024)
• Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France. (1 mai 2024)
• Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program. (3 oct. 2023)
• [Adapted physical activity and metastatic cancer: What needs and expectations?]. (1 déc. 2022)